🎙 Listen to the full episode on Spotify, Apple, and YouTube.
For 30+ years, Eugene Buff has been the behind-the-scenes “bridge” between breakthrough science and the companies that actually bring it to market—from university tech transfer offices drowning in inventions to global corporates hunting for the next edge. He’s a MD/PhD geneticist, a former Harvard Medical School researcher whose papers still get cited… and the rare operator who walked away from NIH funding to pursue commercialization full-time.
In this conversation with Haggai Klorman Eraqi, Eugene tells the story of how he realized the Nobel line was “too long,” and reinvented himself as an innovation strategist who helps organizations answer the hard question: Is this worth building—or should we kill it fast?
You’ll hear:
Why you’re not commercializing inventions—you’re solving problems
The surprising reason Eugene’s default approach is to try to kill the project
What “open innovation” really means
How strategic partnerships, licensing, sponsored research, and venture differ
When getting a patent is the wrong move
If you’re building “deep tech,” spinning out IP, or trying to land a corporate partner without getting crushed by bureaucracy—this episode is for you.
CONNECT WITH EUGENE BUFF
CONNECT WITH HAGGAI
FOLLOW AGGAEUS
SPONSORS
Kardz.Biz — “A business card too good to give away.”
INQUIRIES
💼 Sponsorships / Business: talktous@aggaeus.com
🎙 Podcast: DM via Instagram
Some links may earn affiliate commissions. Offers, terms, and availability may change without notice.
Aggaeus content is for informational and educational purposes only and should not be considered legal, business, investment, or tax advice. You should conduct your own research and consult qualified professionals before making any decisions.
We may feature companies, products, or entities in which Aggaeus, its affiliates, or the author have invested or may invest, or with which they have had, have, or may have a financial, professional, or other relationship.
#OpenInnovation #DeepTech #TechTransfer #StartupStrategy #Innovation
